Category Archives: Cancer and neoplasms
Oct
TUESDAY, Oct. 24, 2023 (HealthDay News) — Childhood cancer survivors who are carriers of cancer predisposing variants have increased subsequent malignant neoplasm-related late mortality, according to a study published in the October issue of The Lancet Oncology. Cheng Chen, from the Shanghai Jiao Tong University School of Medicine, and colleagues used data from two retrospective cohort […]
Cancer and neoplasms
What We’re Reading: Self-Administered Flu Vaccine; Expanded Infertility Definition; EPA Proposes Ban on TCE
Oct
AstraZeneca’s FluMist Quadrivalent Seeks FDA Approval for Self-Administration The FDA has accepted AstraZeneca’s its application for review, seeking approval for patients or caregivers to administer its nasal flu vaccine, FluMist Quadrivalent, according to Reuters. If approved, this vaccine could mark the first self-administered flu vaccine that does not require a health care practitioner for administration. […]
Oct
Here are answers to some frequently asked questions about Pemazyre. How does Pemazyre work? Pemazyre is a targeted therapy. It’s designed to slow or stop the growth of cancer cells. It works by inhibiting (blocking) specific proteins in cancer cells from functioning. Pemazyre targets fibroblast growth factor receptor proteins that are abnormal due to changes […]
Oct
1The Second Clinical College of Zhejiang Chinese Medical University, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, People’s Republic of China; 2Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Zhejiang Chinese Medical University (Xinhua Hospital of Zhejiang Province), Hangzhou, Zhejiang, People’s Republic of China Introduction: Endometriosis-associated ovarian cancer (EAOC) is rare, occurring approximately in 1% […]
Cancer and neoplasms
Anti-tumor activity of a recombinant measles virus against canine lung cancer cells
Oct
Abstract Canine primary lung cancer with metastasis has a poor prognosis with no effective treatment. We previously generated a recombinant measles virus (MV) that lost binding affinity to a principal receptor, SLAM, to eliminate its virulence as a new cancer treatment strategy. The virus, rMV-SLAMblind, targets nectin-4, recently listed as a tumor marker, and exerts […]
